AccessAfrica 2 presented the ethical and regulatory challenges and concerns in safeguarding healthy volunteers in phase 1 clinical trial in a resource-limited setting (sub-Saharan Africa)
Inspections are conducted to verify compliance of Clinical Trial sites with GCP which provides assurance that the rights, safety and well-being of trial subjects are protected, and that the results of the clinical trials are accurate and credible.
A multidisciplinary team was appointed for the revision of the National Joint Scientific and Ethical Review Guidelines.
AccessAfrica2 receives 600.000 Euro from Horizon Europe and will be coordinated from the Centre for Medical Ethics at the University of Oslo.
